1.冯陶.前列腺特异性抗原及其应用/夏同礼［J］.前列腺癌的基础与临床.2000：69-88.

2.黄循.前列腺癌的诊断-PSA/顾方六［J］.现代前列腺病学.2002：346-360.

3.李鸣.前列腺特异抗原及其他肿瘤标志物在前列腺癌早期检测中的应用［J］.中国医师进修杂志，2006，29（2），5-7.

4.Cao K-Y，Mao X-P，Wang D-H，et al. High expression of PSM-E correlated with tumor grade in prostate cancer：a new alternatively spliced variant of prostate-specific membrane antigen［J］. Prostate. 2007 Dec 1；67（16）：1791-1800.

5.Setlur SR，Royce TE，Sboner A，et al. Integrative microarray analysis of pathways dysregulated in metastatic prostate cancer［J］. Cancer Res. 2007 Nov 1；67（21）：10296-10303.

6.Stephan C，Jung K，Lein M，et al. PSA and other tissue kallikreins for prostate cancer detection［J］. Eur J Cancer，2007，43（13）：1918-1926.

7.马逸，陈斌.现阶段PSA在诊疗前列腺癌中的作用［J］.中国卫生检验杂志，2008（4）：766-768.

8.Jiang M，Li M，Fu X，et al. Simultaneously detection of genomic and expression alterations in prostate cancer using cDNA microarray［J］. Prostate，2008，68（14）：1496-1509.

9.Woodson K，O’Reilly KJ，Hanson JC，et al. The usefulness of the detection of GSTP1 methylation in urine as a biomarker in the diagnosis of prostate cancer［J］. J Urol，2008，179（2）：508-511；discussion 511-512.

10.Abrahamsson P-A，Artibani W，Chapple CR，et al. European Association of Urology position statement on screening for prostate cancer［J］. Eur Urol，2009，56（2）：270-271.

11.Andriole GL，Crawford ED，Grubb RL，et al. Mortality results from a randomized prostate-cancer screening trial［J］. N Engl J Med，2009，360（13）：1310-1319.

12.Antunes AA，Leite KR，Sousa-Canavez JM，et al. The role of prostate specific membrane antigen and pepsinogen C tissue expression as an adjunctive method to prostate cancer diagnosis［J］. J Urol，2009，181（2）：594-600.

13.Baden J，Green G，Painter J，et al. Multicenter evaluation of an investigational prostate cancer methylation assay［J］. J Urol，2009，182（3）：1186-1193.

14.You B，Girard P，Paparel P，et al. Prognostic value of modeled PSA clearance on biochemical relapse free survival after radical prostatectomy［J］. Prostate，2009，69（12）：1325-1333.

15.Erbersdobler A，Isbarn H，Dix K，et al. Prognostic value of microvessel density in prostate cancer：a tissue microarray study［J］. World J Urol. 2010 Dec；28（6）：687-692.

16.Pinsky PF，Blacka A，Kramer BS，et al. Assessing contamination and compliance in the prostate component of the Prostate，Lung，Colorectal，and Ovarian（PLCO）Cancer Screening Trial［J］. Clin Trials，2010，7（4）：303-311.

17.Wolf AMD，Wender RC，Etzioni RB，et al. American Cancer Society guideline for the early detection of prostate cancer：update 2010［J］. CA Cancer J Clin，2010，60（2）：70-98.

18.Etzioni R，Gulati R，Tsodikov A，et al. The prostate cancer conundrum revisited：treatment changes and prostate cancer mortality declines［J］. Cancer，2012，118（23）：5955-5963.

19.韩苏军，张思维，陈万青，等.中国前列腺癌发病现状和流行趋势分析［J］.临床肿瘤学杂志，2013（4）：330-334.

20.叶定伟，顾成元.从大样本临床研究看PSA筛查检出前列腺癌的意义［J］.现代泌尿外科杂志，2014（2）：75-79.

21.Pang KH，Rosario DJ，Morgan SL，et al. Evaluation of a short RNA within Prostate Cancer Gene 3 in the predictive role for future cancer using non-malignant prostate biopsies［J］. PLoS ONE，2017，12（4）：e0175070.